These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33714200)

  • 41. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
    Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z
    Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated
    Cheng Q; Wang W; Liu J; Lv Z; Ji W; Yu J; Zhang W; Yang Y
    Front Immunol; 2023; 14():1173848. PubMed ID: 37207207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Analysis of Mutation Status and Immune Landscape for Squamous Cell Carcinomas at Different Anatomical sites.
    Ti W; Wei T; Wang J; Cheng Y
    Front Immunol; 2022; 13():947712. PubMed ID: 35935970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
    Wang K; Chen X; Jin C; Mo J; Jiang H; Yi B; Chen X
    Aging (Albany NY); 2020 Nov; 13(1):675-693. PubMed ID: 33260154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlate tumor mutation burden with immune signatures in human cancers.
    Wang X; Li M
    BMC Immunol; 2019 Jan; 20(1):4. PubMed ID: 30634925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining.
    Zhou W; Fang D; He Y; Wei J
    J Gastrointest Oncol; 2021 Jun; 12(3):1117-1131. PubMed ID: 34295561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global microarray profiling identified
    Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
    J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy.
    Yuan C; Xiang L; Cao K; Zhang J; Luo Y; Sun W; Zhang N; Ren J; Zhang J; Gong Y; Xie C
    Aging (Albany NY); 2020 Mar; 12(5):4603-4616. PubMed ID: 32165590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multi-Level Analysis and Identification of Tumor Mutational Burden Genes across Cancer Types.
    Wang S; Tong Y; Zong H; Xu X; Crabbe MJC; Wang Y; Zhang X
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
    Li Z; Gao H; Zhang X; Liu Q; Chen G
    BMC Gastroenterol; 2022 Sep; 22(1):427. PubMed ID: 36153509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma.
    Li M; Wang Z; Zhu L; Shui Y; Zhang S; Guo W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33834191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Mei J; Wang R; Xia D; Yang X; Zhou W; Wang H; Liu C
    DNA Cell Biol; 2020 Oct; 39(10):1838-1849. PubMed ID: 32876480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and analysis of immune-related subtypes of hepatocellular carcinoma.
    Wang Q; Huang J; Zhang H; Liu H; Yu M
    Exp Biol Med (Maywood); 2021 Mar; 246(6):667-677. PubMed ID: 33231514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.